Explainer-Will Bayer's proposed $7.25 billion Roundup deal bring legal closure? [Yahoo! Finance Canada]
BAYER AG S/ADR (BAYRY)
NASDAQ:AMEX Investor Relations:
investor.bayer.com
Company Research
Source: Yahoo! Finance Canada
Feb 19 (Reuters) - Bayer's Monsanto unit has proposed a $7.25 billion nationwide class settlement to resolve both current and future lawsuits alleging that its Roundup weedkiller caused cancer, billing it as a long-awaited path toward ending years of litigation. Here's a look at whether it could deliver the legal ?certainty Bayer needs. WHAT IS BAYER PROPOSING? The settlement, which still needs a court's approval, would make payments over up to 21 years, funding a long-term claims program for people ?who allege Roundup exposure caused non-Hodgkin lymphoma, an often-fatal cancer of the lymphatic system. Individual payments would vary depending on the age of the person, their exposure and the severity of their cancer. Some patients with occupational exposure diagnosed with aggressive ?non-Hodgkin lymphoma before age 60 could receive an average of $165,000. Patients older than 78 with a qualifying diagnosis would receive $10,000. The settlement would cover the majority of the ex
Show less
Read more
Impact Snapshot
Event Time:
BAYRY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BAYRY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BAYRY alerts
High impacting BAYER AG S/ADR news events
Weekly update
A roundup of the hottest topics
BAYRY
News
- Cancer-linked pesticide in the spotlight after controversial order: 'Toxic by design' [FOX News]FOX News
- Bayer Reports Results for the Investigational Targeted Radionuclide Therapy ²²5Ac-PSMA-Trillium in Advanced Metastatic Prostate CancerBusiness Wire
- Trump angering MAHA with glyphosate order gives Democrats an opening [CNBC]CNBC
- Bayer’s XOFIGO® (radium-223 dichloride) Plus Enzalutamide Demonstrates Significant Overall Survival Benefit in PEACE-3 Trial in Patients With Metastatic Castration-Resistant Prostate Cancer With Bone MetastasesBusiness Wire
- Lawyers for US cancer sufferers challenge Bayer's $7.25bn Roundup settlement deal [Yahoo! Finance]Yahoo! Finance